PATENT CLAIM ANALYSIS

Application Number: 16206448
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["424", "186100"]

Abstract:
The present invention provides recombinant adenoviral compositions and methods for their use in treating disorders associated with epithelial tissues.

Claim (Index 4):
The isolated peptide of  claim 1 , comprising the amino acid sequence: (SEQ ID NO: 4) TLWTGPKPEA NCIIEYGKQN PDSKLTLILV KNGG(I/L)VNGYV   TLMGASDYVN TLFKNKNVSI NVELYFDATG HILPDSSSLK   TDLE X2 \u2003 X3 YKQT AD  X4 \u2003 SARGFMP STTAYPF X5 \u2003 LPNAGTHN   X6 N X7 IFGQCYY  X8 \u2003 ASDGALFPLEVTV MLNKRLPDSR   TSYVMTFLWS L  X9 \u2003 AGLAPETT QATLITSPFT FSYIREDD.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 98.0
- Lexical Diversity: 1.0
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15593578', '14429803', '13158246', '14066353', '15538975']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7930042172894446
- 35 USC 102 Novelty (BERT): 0.6315571945184082
- Combined Prediction Score: 0.776859515012341
- Mean Citation Score: 620.776718
- Max Citation Score: 795.7945599999997
- Similarity Product: 516.2408475750731

Labels:
- Claim Label 101: 0
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test